| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f12ab2f0607416e3772426c72ed27400 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-77 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-77 |
| filingDate |
2015-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8ad48389a12b913d34c9ac14bae2679
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3300dadcd8ac5490a66fe716fad1ecb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52cb0ccc0b1ac6cdc0ec43e2b71efec3 |
| publicationDate |
2016-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016007542-A1 |
| titleOfInvention |
Poloxamer therapy for heart failure |
| abstract |
Provided herein uses of poloxamer 188, such as a long-circulating material free (LCMF) poloxamer 188, and methods of administering the poloxamer for treating heart failure by only a single infusion, or by a single infusion followed by additional infusions at intervals of 1 - 4 weeks. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023018347-A1 |
| priorityDate |
2014-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |